CoagulationDisorders near Largo, FL

Care Philosophy: Dr Chavez is an Associate Member in the Lymphoma Section of the Department of Malignant Hematology at Moffitt Cancer Center. Dr Chavez earned his MD from the Medical School at the Universidad Peruana Cayetano Heredia in Lima, Peru. He completed his residency in Hematology at Hospital Edgardo Rebagliati Martins/Universidad Peruana Cayetano Heredia in Lima, Peru. He did his Internal Medicine training at the State University of New York in Buffalo, New York and completed his Medical Oncology training at the University of South Florida/Moffitt Cancer Center. Dr Chavez is board-certified in Internal Medicine and Medical Oncology.

Care Philosophy: Dr Kenneth Shain is an associate member in the Malignant Hematology program in the Department of Malignant Hematology, Tumor Biology, and the Chemical Biology and Molecular Medicine Program. Dr Shain has also been appointed as an Assistant Professor at the University of South Florida Morsani College of Medicine in the Department of Oncologic Sciences.Dr Shain is also a Director of the Myeloma Research Center.Dr Shain is a clinician scientist with time divided by clinic, clinic trials and translational research with a primary focus in multiple myeloma and other plasma cell relation disorders (including Waldenstrom Macroglobulinemia and Primary Amyloidosis).

Care Philosophy: Jhanelle E Gray, MD is the Department Chair, Program Leader and a Senior Member for Thoracic Oncology at the Moffitt Cancer Center (MCC), co-Leader of the Cancer Center Support Grant Molecular Medicine Program and Professor in the Department of Oncologic Sciences at the University of South Florida Morsani College of Medicine. A renowned Thoracic medical oncologist and clinical scientist, Dr Gray is actively involved and leads numerous clinical research trials that investigate novel immunotherapeutic and targeted therapy drug combinations for lung cancer which have greatly influenced standard of care treatment. Her research has generated over 80 publications in scholarly, peer-reviewed journals, including original manuscripts and reviews.

Care Philosophy: Dr Richard Levine is the Medical Director at Moffitt International Plaza (MIP). Dr Levine received his MD and MS in Pharmacology from Indiana University. He completed an internal medicine residency at the University of Cincinnati Medical Center and a medical oncology fellowship at the National Cancer Institute, Medical Branch. He joins Moffitt from Space Coast Cancer Center, where he served as President and founder. Dr Levine was the Chairman of the Cancer Committee and Tumor Board of Parrish Medical Center and Cape Canaveral Hospital for 25 years.

Biography: Dr. Reshma Ramlal clinical interest focuses on the care of patients undergoing allogeneic transplantation for myeloid malignancies. Prior to joining Moffitt, Dr. RamlaI was a Malignant Hematologist and Bone Marrow Transplantation physician at the University of Kentucky, Markey Cancer Center for 8 years. She joined the Markey Cancer Center after completion of her BMT fellowship at the MD Anderson Cancer Center. During her time in Kentucky, she served as the Interim Medical Director of the Bone Marrow Transplantation and Cellular Therapy program for two years. She is dedicated to delivering high-quality medical care with compassion and understanding. Dr. Ramlal research interests include methods to mitigate complications of allogeneic transplantation and improve clinical outcomes.

Care Philosophy: Dr Bruna Pellini is an Assistant Member at the Department of Thoracic Oncology at Moffitt Cancer Center and Research Institute and an Assistant Professor at Morsani College of Medicine at the University of South Florida. She specializes in the care of patients diagnosed with lung cancer. Dr Pellini received her medical degree from Universidade Federal do Rio Grande do Sul, Brazil and completed her internal medicine residency at University of Central Florida College of Medicine followed by her medical oncology fellowship at Washington University School of Medicine in St. Louis.

Care Philosophy: Dr Markowitz is interested in cutaneous oncology and melanoma in particular. He will engage in clinical translational research efforts in tumor immunology and immunotherapy.

Care Philosophy: Dr Eroglu is a medical oncologist in the Department of Cutaneous Oncology at Moffitt Cancer Center and an assistant professor in the Department of Oncologic Sciences at the University of South Florida Morsani College of Medicine. Her clinical focus is on treating patients with advanced melanoma and other skin cancers, including basal cell carcinoma and Merkel cell carcinoma, and participating in clinical trials.Dr Eroglu's research interests are translational and clinical research in targeted therapies and combination immunotherapeutics for melanoma and other skin cancers, along with development of personalized treatment strategies and biomarkers for patients with melanoma.

Care Philosophy: Dr Extermann is Program Leader in the Senior Adult Oncology Program at Moffitt Cancer Center. Dr Martine Extermann is also a Professor of Oncology and Medicine at the University of South Florida. She earned her medical degree and a PhD at the University of Geneva, Switzerland. She has a Swiss Board Certification in Internal Medicine, specializing in Hematology-Oncology. She also holds ABIM certifications in Internal Medicine and Medical Oncology. She has worked at Moffitt since 1994 and has been a faculty member since 1997. Her clinical activity and research focus on cancer in older patients.

Care Philosophy: Dr Vogelbaum is an internationally known leader in neurosurgical oncology and a distinguished investigator in laboratory research, translational and clinical trials in gliomas. Dr Vogelbaum is currently Chief of Neurosurgery and Program Leader of the Department of Neuro-Oncology at Moffitt Cancer Center. He has served on or led numerous scientific committees and holds an array of honors and awards, as well as leadership positions at the regional, national, and international levels. He is the principal investigator and co-investigator of a broad range of early-phase investigator-initiated therapeutic trials, both national and international multisite collaborative studies. He has published over 190 peer-reviewed and invited articles.